Case File №
#VI-2026-0208
Pharma Grade Peptides
Request Full Data Access to the VendorInvestigator database of peptide tests.
Exhibit I
Compounds on File
43 LINE ITEMS| Compound | Grade | Samples | Mean | Min | Max | Latest |
|---|---|---|---|---|---|---|
| GHK-Cu | A Great | 2 | 10.0 | 10.0 | 10.0 | 6 May 2025 |
| Tirzepatide | A Great | 2 | 7.1 | 6.5 | 7.6 | 21 May 2025 |
| Retatrutide | B Good | 2 | 6.3 | 6.3 | 6.3 | 7 May 2025 |
| Semaglutide | C Okay | 2 | 5.1 | 5.1 | 5.2 | 7 May 2025 |
| Melanotan II | D Poor | 2 | 4.8 | 4.8 | 4.8 | 21 May 2025 |
| PT-141 | D Poor | 2 | 5.2 | 3.2 | 7.2 | 7 May 2025 |
| BPC-157 | E Bad | 2 | 3.6 | 3.4 | 3.8 | 6 May 2025 |
| CJC-1295 | E Bad | 2 | 2.9 | 2.9 | 2.9 | 7 May 2025 |
| Mazdutide | E Bad | 2 | 4.0 | 3.9 | 4.0 | 6 May 2025 |
| ACE-031 | X N/A | 1 | 4.8 | 4.8 | 4.8 | 13 Feb 2025 |
| AICAR | X N/A | 1 | 4.0 | 4.0 | 4.0 | 14 Jan 2025 |
| Anastrozole (Arimidex) Raw | X N/A | 1 | 4.0 | 3.7 | 3.7 | 17 Dec 2024 |
| BAC Water | X N/A | 1 | 6.4 | 6.4 | 6.4 | 2 Jul 2025 |
| BMK glycidic acid (P-2-P methyl glycidic acid / sodium salt) CAS 5449-12-7 | X N/A | 1 | 6.8 | 6.8 | 6.8 | 13 Jun 2025 |
| BMK methyl glycidate CAS 80532-66-7 | X N/A | 1 | 4.0 | 2.5 | 2.5 | 17 Dec 2024 |
| BPC-157 Arg Oral | X N/A | 1 | 4.3 | 4.3 | 4.3 | 20 Jun 2025 |
| BPC157 5mg + TB500 5mg Blend | X N/A | 1 | 4.0 | 1.8 | 1.8 | 13 Jun 2025 |
| Cagrilintide 5mg + Semaglutide 5mg Blend | X N/A | 1 | 4.0 | 4.0 | 4.0 | 21 May 2025 |
| CJC-1295 w/o DAC 10mg + IPA 10mg Blend | X N/A | 1 | 6.2 | 6.2 | 6.2 | 2 Apr 2025 |
| Crystagen | X N/A | 1 | 4.5 | 4.5 | 4.5 | 3 Jul 2025 |
| Drostanolone Propionate (Mast P) Raw | X N/A | 1 | 5.6 | 5.6 | 5.6 | 24 Apr 2025 |
| GHRP-6 Acetate | X N/A | 1 | 7.3 | 7.3 | 7.3 | 13 Jun 2025 |
| GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | X N/A | 1 | 8.0 | 8.0 | 8.0 | 16 Mar 2025 |
| Glutathione | X N/A | 1 | 7.4 | 7.4 | 7.4 | 6 May 2025 |
| IGF-1 LR3 | X N/A | 1 | 4.0 | 1.5 | 1.5 | 13 Feb 2025 |
| KissPeptin-10 | X N/A | 1 | 4.6 | 4.6 | 4.6 | 21 May 2025 |
| Letrozole | X N/A | 1 | 8.1 | 8.1 | 8.1 | 14 Jan 2025 |
| Lipo-B 216mg | X N/A | 1 | 5.2 | 5.2 | 5.2 | 3 Jun 2025 |
| Methylene Blue | X N/A | 1 | 4.1 | 4.1 | 4.1 | 13 Feb 2025 |
| N-Acetyl Epitalon Amidate | X N/A | 1 | 8.7 | 8.7 | 8.7 | 21 May 2025 |
| NA Semax Amidate | X N/A | 1 | 4.9 | 4.9 | 4.9 | 11 Jun 2025 |
| NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | X N/A | 1 | 6.9 | 6.9 | 6.9 | 2 Apr 2025 |
| NAD+ Injectable | X N/A | 1 | 6.0 | 6.0 | 6.0 | 8 Jul 2025 |
| PMK methyl glycidate CAS 1369021-80-6 | X N/A | 1 | 5.4 | 5.4 | 5.4 | 21 May 2025 |
| PTD-DBM | X N/A | 1 | 7.5 | 7.5 | 7.5 | 2 Jul 2025 |
| Salbutamol | X N/A | 1 | 5.3 | 5.3 | 5.3 | 24 Apr 2025 |
| Semaglutide Raw | X N/A | 1 | 7.5 | 7.5 | 7.5 | 17 Dec 2024 |
| SNAP-8 | X N/A | 1 | 6.6 | 6.6 | 6.6 | 14 Jan 2025 |
| Test Enanthate | X N/A | 1 | 4.6 | 4.6 | 4.6 | 9 Jun 2025 |
| Testosterone Cypionate Raw | X N/A | 1 | 4.9 | 4.9 | 4.9 | 24 Apr 2025 |
| Trenbolone Acetate | X N/A | 1 | 4.0 | 3.7 | 3.7 | 2 Jul 2025 |
| Vilon | X N/A | 1 | 5.5 | 5.5 | 5.5 | 14 Jan 2025 |
| YK11 | X N/A | 1 | 7.7 | 7.7 | 7.7 | 25 Apr 2025 |
Exhibit II
Evidence Log
41 LABORATORY RETURNS| Filed | Compound | Score | Claimed | Found | Δ Qty | Purity | Batch № | Lab | Source |
|---|---|---|---|---|---|---|---|---|---|
| 25 May 2026 | PTD-DBM | 8.9 A | 5mg | 5.6mg | +12.1% | 97.82% | c3gus2 | Lab E | Community |
| 25 May 2026 | Trenbolone Acetate | 4.3 C | 200mg/ml | 235.7mg/ml | +17.9% | 98.58% | apat29 | Lab B | Community |
| 25 May 2026 | YK11 | 8.7 A | 100mg | 98.0mg | -2.0% | 95.61% | c2e38q | Lab F | Public |
| 24 May 2026 | Drostanolone Propionate (Mast P) Raw | 4.5 C | 1g | 1.2g | +21.0% | 97.12% | ka9a5f | Lab B | Public |
| 24 May 2026 | BMK methyl glycidate CAS 80532-66-7 | 4.3 C | 100g | 89.5g | -10.5% | 96.22% | vassbw | Lab D | Public |
| 24 May 2026 | Crystagen | 4.0 C | 2mg | 1.7mg | -12.9% | 97.91% | et2bwm | Lab C | Community |
| 24 May 2026 | NA Semax Amidate | 5.1 B | 5mg | 5.4mg | +7.4% | 97.18% | wp74fb | Lab A | Public |
| 23 May 2026 | GHRP-6 Acetate | 7.4 A | 5mg | 5.7mg | +13.7% | 97.16% | fgxnh7 | Lab D | Community |
| 23 May 2026 | Vilon | 6.7 A | 10mg | 11.4mg | +13.7% | 97.87% | pi79z8 | Lab B | Public |
| 23 May 2026 | BMK glycidic acid (P-2-P methyl glycidic acid / sodium salt) CAS 5449-12-7 | 6.2 A | 500g | 504.2g | +0.8% | 98.90% | 0nns3j | Lab D | Public |
| 21 May 2026 | BPC157 5mg + TB500 5mg Blend | 4.0 C | 2mg | 2.3mg | +13.4% | 97.35% | silcdu | Lab A | Public |
| 21 May 2026 | Glutathione | 6.2 A | 30mg | 30.3mg | +0.9% | 96.41% | 82bgp7 | Lab A | Community |
| 21 May 2026 | Letrozole | 7.9 A | 20mg | 21.3mg | +6.4% | 97.91% | ei6x0h | Lab A | Public |
| 20 May 2026 | IGF-1 LR3 | 4.0 C | 15mg | 12.8mg | -14.4% | 97.10% | hp6db3 | Lab E | Public |
| 19 May 2026 | N-Acetyl Epitalon Amidate | 10.0 A | 30mg | 32.5mg | +8.3% | 99.05% | t6uvun | Lab D | Public |
| 17 May 2026 | ACE-031 | 6.9 A | 30mg | 31.0mg | +3.5% | 97.75% | 6ka8lj | Lab D | Community |
| 17 May 2026 | AICAR | 4.0 C | 10mg | 11.3mg | +13.2% | 98.67% | vws51t | Lab A | Public |
| 17 May 2026 | KissPeptin-10 | 4.1 C | 5mg | 5.7mg | +14.0% | 95.44% | llw9kc | Lab C | Public |
| 29 Jan 2026 | Testosterone Cypionate Raw | 5.3 B | 500g | 473.8g | -5.2% | 98.60% | xye1om | Lab B | Public |
| 9 Jan 2026 | PMK methyl glycidate CAS 1369021-80-6 | 6.0 A | 100g | 124.1g | +24.1% | 98.34% | eat9ad | Lab B | Community |
| 7 Jan 2026 | Anastrozole (Arimidex) Raw | 5.2 B | 5g | 4.6g | -7.7% | 97.36% | 3blljy | Lab A | Public |
| 7 Jan 2026 | BPC-157 Arg Oral | 4.0 C | 20mg | 20.7mg | +3.3% | 96.29% | bw3adx | Lab E | Public |
| 7 Jan 2026 | Cagrilintide 5mg + Semaglutide 5mg Blend | 5.5 B | 30mg | 29.3mg | -2.3% | 95.63% | k70e0o | Lab E | Public |
| 7 Jan 2026 | Lipo-B 216mg | 4.7 C | 250mg/ml | 277.8mg/ml | +11.1% | 97.82% | kqrfrj | Lab A | Community |
| 7 Jan 2026 | Salbutamol | 5.3 B | 20mg | 19.4mg | -2.9% | 98.33% | 2ruo6l | Lab A | Public |
| 6 Jan 2026 | Methylene Blue | 4.0 C | 10mg | 10.4mg | +3.8% | 99.19% | 58uudl | Lab B | Public |
| 6 Jan 2026 | NAD+ Injectable | 6.1 A | 100mg/ml | 97.7mg/ml | -2.3% | 96.05% | 6g2ph3 | Lab E | Community |
| 5 Dec 2025 | GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | 9.3 A | 10mg | 9.7mg | -3.4% | 97.90% | y4nyik | Lab C | Public |
| 5 Dec 2025 | Semaglutide Raw | 9.1 A | 10g | 11.3g | +13.3% | 98.03% | fz3ewl | Lab A | Public |
| 5 Nov 2025 | SNAP-8 | 6.9 A | 5mg | 5.6mg | +11.8% | 97.37% | 3vawkn | Lab A | Public |
| 4 Nov 2025 | BAC Water | 5.9 B | 50mg | 45.2mg | -9.6% | 96.06% | pn6fq0 | Lab D | Public |
| 17 Oct 2025 | CJC-1295 w/o DAC 10mg + IPA 10mg Blend | 6.8 A | 30mg | 35.5mg | +18.3% | 98.98% | 8wmkhd | Lab C | Community |
| 17 Oct 2025 | NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | 6.4 A | 2mg | 2.2mg | +10.3% | 95.81% | 8jmqfj | Lab F | Community |
| 9 Oct 2025 | Test Enanthate | 5.1 B | 200mg/ml | 189.7mg/ml | -5.2% | 99.73% | 9h43u2 | Lab G | Community |
| 21 May 2025 | Tirzepatide | X | 6.5 | 10mg | 8.63mg | -13.7% | 99.35% | White Label / Silver Crimp / Blue Cap | Lab D |
| 21 May 2025 | Melanotan II | X | 4.8 | 10mg | 4.76mg | -52.4% | 99.11% | White Label / Silver Crimp / Yellow Cap | Lab D |
| 21 May 2025 | Tirzepatide | X | 7.6 | 10mg | 9.3mg | -7.0% | 99.16% | White Label / Silver Crimp / Blue Cap | Lab D |
| 21 May 2025 | Melanotan II | X | 4.8 | 10mg | 4.43mg | -55.7% | 99.12% | White Label / Silver Crimp / Yellow Cap | Lab D |
| 7 May 2025 | PT-141 | X | 7.2 | 10mg | 8.15mg | -18.5% | 99.89% | White Label / Silver Crimp / Blue Cap | Lab A |
| 7 May 2025 | CJC-1295 | DAC X | 2.9 | 10mg | 1.16mg | -88.4% | 75.19% | White Label / Copper Crimp / Clear Cap | Lab A |
| 7 May 2025 | CJC-1295 | DAC X | 2.9 | 10mg | 1.1mg | -89.0% | 75.19% | White Label / Copper Crimp / Clear Cap | Lab A |
— END OF EVIDENCE LOG —